Reported Earnings • Apr 28
First quarter 2026 earnings released: EPS: CN¥0.05 (vs CN¥0.05 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.05 (in line with 1Q 2025). Revenue: CN¥2.87b (up 38% from 1Q 2025). Net income: CN¥90.6m (down 12% from 1Q 2025). Profit margin: 3.2% (down from 5.0% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Annuncio • Apr 28
Sichuan Development Lomon Co.,Ltd., Annual General Meeting, May 27, 2026 Sichuan Development Lomon Co.,Ltd., Annual General Meeting, May 27, 2026, at 14:50 China Standard Time. Location: 15F, Tower B, No. 151, Tianfu 2nd Street, Hi-tech Zone, Chengdu, Sichuan China Annuncio • Mar 31
Sichuan Development Lomon Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Sichuan Development Lomon Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Valuation Update With 7 Day Price Move • Feb 25
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥13.75, the stock trades at a trailing P/E ratio of 46.3x. Average trailing P/E is 50x in the Chemicals industry in China. Total returns to shareholders of 27% over the past three years. New Risk • Feb 15
New major risk - Revenue and earnings growth Earnings have declined by 14% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risk Paying a dividend despite having no free cash flows. Annuncio • Dec 31
Sichuan Development Lomon Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 31, 2026 Sichuan Development Lomon Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 31, 2026 Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥12.90, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years. Reported Earnings • Oct 24
Third quarter 2025 earnings released: EPS: CN¥0.098 (vs CN¥0.07 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.098 (up from CN¥0.07 in 3Q 2024). Revenue: CN¥2.69b (up 33% from 3Q 2024). Net income: CN¥198.1m (up 51% from 3Q 2024). Profit margin: 7.4% (up from 6.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Annuncio • Sep 30
Sichuan Development Lomon Co.,Ltd. to Report Q3, 2025 Results on Oct 24, 2025 Sichuan Development Lomon Co.,Ltd. announced that they will report Q3, 2025 results on Oct 24, 2025 Reported Earnings • Aug 20
Second quarter 2025 earnings released: EPS: CN¥0.084 (vs CN¥0.10 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.084 (down from CN¥0.10 in 2Q 2024). Revenue: CN¥2.62b (up 11% from 2Q 2024). Net income: CN¥135.5m (down 29% from 2Q 2024). Profit margin: 5.2% (down from 8.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Annuncio • Jul 02
Sichuan Development Lomon Co.,Ltd. to Report First Half, 2025 Results on Aug 19, 2025 Sichuan Development Lomon Co.,Ltd. announced that they will report first half, 2025 results on Aug 19, 2025 Annuncio • May 31
Sichuan Development Lomon Co.,Ltd. Approves Dividend for the Year 2024 Sichuan Development Lomon Co.,Ltd. approved at its AGM held on 29 May 2025 the cash dividend/10 shares (tax included) of CNY 1.41000000 for the year 2024. Board Change • May 07
High number of new directors There are 6 new directors who have joined the board in the last 3 years. President & Non-Independent Director Liwei Wang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Annuncio • Apr 25
Sichuan Development Lomon Co.,Ltd. Proposes Final Cash Dividend for 2024 Sichuan Development Lomon Co.,Ltd. proposed final cash dividend of CNY 1.41000000 per 10 shares (tax included) for 2024. Reported Earnings • Apr 24
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: EPS: CN¥0.28 (up from CN¥0.22 in FY 2023). Revenue: CN¥8.18b (up 6.1% from FY 2023). Net income: CN¥532.9m (up 29% from FY 2023). Profit margin: 6.5% (up from 5.4% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Annuncio • Apr 23
Sichuan Development Lomon Co.,Ltd., Annual General Meeting, May 29, 2025 Sichuan Development Lomon Co.,Ltd., Annual General Meeting, May 29, 2025, at 14:30 China Standard Time. Location: 15F, Tower B, No. 151, Tianfu 2nd Street, Hi-tech Zone, Chengdu, Sichuan China Annuncio • Mar 31
Sichuan Development Lomon Co.,Ltd. to Report Q1, 2025 Results on Apr 28, 2025 Sichuan Development Lomon Co.,Ltd. announced that they will report Q1, 2025 results on Apr 28, 2025 Valuation Update With 7 Day Price Move • Jan 17
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥14.58, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 28% over the past three years. Annuncio • Dec 31
Sichuan Development Lomon Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025 Sichuan Development Lomon Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025 Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥15.01, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 19% over the past three years. Valuation Update With 7 Day Price Move • Nov 25
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥17.22, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 28% over the past three years. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to CN¥16.52, the stock trades at a forward P/E ratio of 44x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years. Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.043 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.07 (up from CN¥0.043 in 3Q 2023). Revenue: CN¥2.03b (up 13% from 3Q 2023). Net income: CN¥131.2m (up 41% from 3Q 2023). Profit margin: 6.5% (up from 5.2% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Oct 24
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to CN¥12.25, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.38 per share. Annuncio • Sep 30
Sichuan Development Lomon Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Sichuan Development Lomon Co.,Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥9.71, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.17 per share. Valuation Update With 7 Day Price Move • Sep 03
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to CN¥8.17, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.06 per share. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.048 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.10 (up from CN¥0.048 in 2Q 2023). Revenue: CN¥2.35b (up 42% from 2Q 2023). Net income: CN¥190.1m (up 133% from 2Q 2023). Profit margin: 8.1% (up from 4.9% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Annuncio • Jun 29
Sichuan Development Lomon Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Sichuan Development Lomon Co.,Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Annuncio • May 23
Sichuan Development Lomon Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on May 24, 2024 Sichuan Development Lomon Co.,Ltd. announced the implementation of 2023 final profit distribution plan of CNY 0.90000000 per 10 shares (tax included) on A shares. The dividend payable on May 24, 2024. Ex-date is May 24, 2024 and the record date is May 23, 2024. Valuation Update With 7 Day Price Move • May 17
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥8.56, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 15% over the past three years. Reported Earnings • Apr 24
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: CN¥0.22 (down from CN¥0.59 in FY 2022). Revenue: CN¥7.71b (down 23% from FY 2022). Net income: CN¥414.3m (down 61% from FY 2022). Profit margin: 5.4% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Annuncio • Apr 23
Sichuan Development Lomon Co.,Ltd., Annual General Meeting, May 15, 2024 Sichuan Development Lomon Co.,Ltd., Annual General Meeting, May 15, 2024, at 14:00 China Standard Time. Location: 15F, Tower B, No. 151, Tianfu 2nd Street, High-tech Zone, Chengdu, Sichuan China Annuncio • Mar 30
Sichuan Development Lomon Co.,Ltd. to Report Q1, 2024 Results on Apr 23, 2024 Sichuan Development Lomon Co.,Ltd. announced that they will report Q1, 2024 results on Apr 23, 2024 Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥5.40, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Annuncio • Dec 30
Sichuan Development Lomon Co., Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024 Sichuan Development Lomon Co., Ltd. announced that they will report fiscal year 2023 results on Apr 23, 2024 Price Target Changed • Nov 02
Price target decreased by 12% to CN¥10.80 Down from CN¥12.30, the current price target is an average from 2 analysts. New target price is 53% above last closing price of CN¥7.05. Stock is down 40% over the past year. The company is forecast to post earnings per share of CN¥0.60 for next year compared to CN¥0.59 last year. Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.043 (vs CN¥0.17 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.043 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥1.79b (down 19% from 3Q 2022). Net income: CN¥93.2m (down 71% from 3Q 2022). Profit margin: 5.2% (down from 15% in 3Q 2022). Revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. New Risk • Aug 10
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.9% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (96% cash payout ratio). Profit margins are more than 30% lower than last year (5.9% net profit margin). Reported Earnings • Aug 10
Second quarter 2023 earnings released: EPS: CN¥0.048 (vs CN¥0.26 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.048 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥1.66b (down 45% from 2Q 2022). Net income: CN¥81.6m (down 84% from 2Q 2022). Profit margin: 4.9% (down from 17% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 14% per year, which means it is tracking significantly ahead of earnings growth. Major Estimate Revision • Jul 20
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥9.95b to CN¥9.51b. EPS estimate also fell from CN¥0.523 per share to CN¥0.457 per share. Net income forecast to shrink 1.3% next year vs 47% growth forecast for Chemicals industry in China . Consensus price target of CN¥12.30 unchanged from last update. Share price rose 4.3% to CN¥8.65 over the past week. Annuncio • Jul 01
Sichuan Development Lomon Co., Ltd. to Report First Half, 2023 Results on Aug 10, 2023 Sichuan Development Lomon Co., Ltd. announced that they will report first half, 2023 results on Aug 10, 2023 Annuncio • Jun 21
Sichuan Development Lomon Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 28 June 2023 Sichuan Development Lomon Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included) of CNY2.20000000. Record date is 27 June 2023. Ex-date is 28 June 2023.Payment date is 28 June 2023. Annuncio • May 19
Sichuan Development Lomon Co., Ltd. Approves Cash Dividend for 2022 Sichuan Development Lomon Co., Ltd. held its Annual General Meeting of 2022 on 17 May 2023, during which the following proposal(s) was/were approved: Cash dividend/10 shares (tax included): CNY 2.20000000. Reported Earnings • Apr 26
Full year 2022 earnings released: EPS: CN¥0.59 (vs CN¥0.63 in FY 2021) Full year 2022 results: EPS: CN¥0.59. Revenue: CN¥10.0b (up 51% from FY 2021). Net income: CN¥1.06b (up 4.7% from FY 2021). Profit margin: 11% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Price Target Changed • Nov 16
Price target increased to CN¥20.59 Up from CN¥11.67, the current price target is provided by 1 analyst. New target price is 72% above last closing price of CN¥12.00. Stock is down 14% over the past year. The company is forecast to post earnings per share of CN¥0.74 for next year compared to CN¥0.63 last year. Board Change • Nov 16
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. Non-Independent Director Jiang Zhu is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.12 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.17 (up from CN¥0.12 in 3Q 2021). Revenue: CN¥2.21b (up 31% from 3Q 2021). Net income: CN¥325.7m (up 59% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Jun 29
Consensus revenue estimates increase by 14% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from CN¥8.93b to CN¥10.2b. EPS estimate increased from CN¥0.47 to CN¥0.69 per share. Net income forecast to grow 1.5% next year vs 40% growth forecast for Chemicals industry in China. Consensus price target up from CN¥11.67 to CN¥20.59. Share price rose 26% to CN¥17.72 over the past week. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥15.52, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 336% over the past three years. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥13.09, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 264% over the past three years. Reported Earnings • Apr 30
First quarter 2022 earnings: EPS exceeds analyst expectations First quarter 2022 results: EPS: CN¥0.16 (up from CN¥0.08 in 1Q 2021). Revenue: CN¥2.33b (up 64% from 1Q 2021). Net income: CN¥273.1m (up 146% from 1Q 2021). Profit margin: 12% (up from 7.8% in 1Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 18%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Non-Independent Director Jiang Zhu is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Annuncio • Apr 15
Sichuan Development Lomon Co., Ltd., Annual General Meeting, May 12, 2022 Sichuan Development Lomon Co., Ltd., Annual General Meeting, May 12, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 annual report and its summary; to consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; and to discuss other matters. Reported Earnings • Apr 13
Full year 2021 earnings: EPS exceeds analyst expectations Full year 2021 results: EPS: CN¥0.63 (up from CN¥0.50 in FY 2020). Revenue: CN¥6.64b (up 28% from FY 2020). Net income: CN¥1.02b (up 52% from FY 2020). Profit margin: 15% (up from 13% in FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 11%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 22
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥16.46, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 27x in the IT industry in China. Total returns to shareholders of 441% over the past three years. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 21% share price decline to CN¥14.15, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 28x in the IT industry in China. Total returns to shareholders of 287% over the past three years. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 29% share price gain to CN¥18.54, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 29x in the IT industry in China. Total returns to shareholders of 450% over the past three years. Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥16.38, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 27x in the IT industry in China. Total returns to shareholders of 396% over the past three years. Reported Earnings • Aug 19
Second quarter 2021 earnings released: EPS CN¥0.34 (vs CN¥0.064 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.63b (up 32% from 2Q 2020). Net income: CN¥577.8m (up CN¥493.9m from 2Q 2020). Profit margin: 35% (up from 6.8% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥12.08, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 25x in the IT industry in China. Total returns to shareholders of 240% over the past three years. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 25x in the IT industry in China. Total returns to shareholders of 168% over the past three years. Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥8.96, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 24x in the IT industry in China. Total returns to shareholders of 120% over the past three years. Reported Earnings • Apr 20
First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.006 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.42b (up 18% from 1Q 2020). Net income: CN¥111.2m (up CN¥102.6m from 1Q 2020). Profit margin: 7.8% (up from 0.7% in 1Q 2020). The increase in margin was driven by higher revenue. Reported Earnings • Apr 04
Full year 2020 earnings released: EPS CN¥0.50 (vs CN¥0.06 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥5.18b (up 171% from FY 2019). Net income: CN¥668.7m (up CN¥584.1m from FY 2019). Profit margin: 13% (up from 4.4% in FY 2019). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥7.12, the stock is trading at a trailing P/E ratio of 11.8x, down from the previous P/E ratio of 13.9x. This compares to an average P/E of 50x in the IT industry in China. Total returns to shareholders over the past year are 40%. Annuncio • Mar 09
Chengdu Santai Holding Group Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021 Chengdu Santai Holding Group Co., Ltd. announced that they will report fiscal year 2020 results on Apr 20, 2021 Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥9.15, the stock is trading at a trailing P/E ratio of 15.1x, up from the previous P/E ratio of 12.2x. This compares to an average P/E of 54x in the IT industry in China. Total returns to shareholders over the past year are 78%. Is New 90 Day High Low • Feb 20
New 90-day high: CN¥8.32 The company is up 34% from its price of CN¥6.23 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is down 23% over the same period. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥7.70, the stock is trading at a trailing P/E ratio of 12.7x, up from the previous P/E ratio of 10.6x. This compares to an average P/E of 54x in the IT industry in China. Total returns to shareholders over the past year are 65%. Is New 90 Day High Low • Jan 22
New 90-day high: CN¥6.74 The company is up 4.0% from its price of CN¥6.45 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is down 24% over the same period. Is New 90 Day High Low • Dec 29
New 90-day low: CN¥5.52 The company is down 11% from its price of CN¥6.18 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is down 24% over the same period. Is New 90 Day High Low • Dec 11
New 90-day low: CN¥5.75 The company is down 9.0% from its price of CN¥6.29 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is down 15% over the same period. Is New 90 Day High Low • Nov 26
New 90-day low: CN¥5.96 The company is down 13% from its price of CN¥6.84 on 26 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the IT industry, which is also down 13% over the same period. Annuncio • Oct 19
ChengDu Santai Holding Group Co.,Ltd. to Report Q3, 2020 Results on Oct 26, 2020 ChengDu Santai Holding Group Co.,Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020 Annuncio • Sep 28
Li Jiaquan completed the acquisition of an additional 7.7% stake in ChengDu Santai Holding Group Co.,Ltd. (SZSE:002312) from Bu Jian. Li Jiaquan agreed to acquire an additional 7.7% stake in ChengDu Santai Holding Group Co.,Ltd. (SZSE:002312) from Bu Jian for approximately CNY 730 million on August 31, 2020. Under the terms, Li Jiaquan will acquire 106.68 million shares at an offer price of CNY 6.84 per share. The consideration will be paid in tranches. Post completion, Li Jiaquan and Bu Jian will hold 13.86% and 17.8% stake in ChengDu Santai Holding Group Co.,Ltd. respectively.
Li Jiaquan completed the acquisition of an additional 7.7% stake in ChengDu Santai Holding Group Co.,Ltd. (SZSE:002312) from Bu Jian on September 23, 2020. Annuncio • Sep 04
ChengDu Santai Holding Group Co.,Ltd. announced that it expects to receive CNY 1.975629824 billion in funding from Sichuan Development Mining Group Co., Ltd. ChengDu Santai Holding Group Co.,Ltd. (SZSE:002312) announced that it has entered into a subscription agreement for a private placement of 385,865,200 A shares at a price of CNY 5.12 per share for gross proceeds of CNY 1,975,629,824 on August 31, 2020. The transaction will include participation from new investor Sichuan Development Mining Group Co., Ltd. for a 21.87% stake in the company. Post closing of the transaction, the capital of the company will increase to 1,763,956,933 shares. The transaction has been approved by the 40th meeting of the fifth board of directors of the company and is subject to the approval of its shareholders, the State-owned Assets Supervision and Administration Department, the State Administration for Market Regulation of China, and the China Securities Regulatory Commission. All securities issued will be subject to a hold period of 18 months from the date of the end of the issuance. Annuncio • Aug 02
ChengDu Santai Holding Group Co.,Ltd. to Report First Half, 2020 Results on Aug 25, 2020 ChengDu Santai Holding Group Co.,Ltd. announced that they will report first half, 2020 results on Aug 25, 2020 
